2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with tamoxifen in 1 studies
Studies (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Trials (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Recent Studies (post-2010) (2-(4-morpholinoanilino)-6-cyclohexylaminopurine) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
85 | 0 | 62 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Clercq, DJ; Hillaert, U; Lievens, S; Martins, JC; Risseeuw, MD; Sinnaeve, D; Tavernier, J; Van Calenbergh, S; Van den Broeck, F | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and tamoxifen
Article | Year |
---|---|
A "clickable" MTX reagent as a practical tool for profiling small-molecule-intracellular target interactions via MASPIT.
Topics: Antimetabolites, Antineoplastic; Cell Survival; Click Chemistry; Cycloaddition Reaction; HEK293 Cells; Humans; Methotrexate; Morpholines; Purines; Signal Transduction; Small Molecule Libraries; STAT3 Transcription Factor; Stereoisomerism; Tacrolimus; Tamoxifen; Tetrahydrofolate Dehydrogenase; Tissue Array Analysis | 2013 |